Global Muscle Relaxant Drugs Market Report By Drug Type (Facial Muscle Relaxant Drugs, Skeletal Muscle Relaxant Drugs, Neuromuscular Blocking Agents), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026

ID:VMR11212130
April 2020
Report Formats:

The global demand for Muscle Relaxant Drugs Market is presumed to reach the valuation of nearly USD XXX MN by 2026 from USD XXX MN in 2019 with a CAGR of X.XX% under the study period of 2020 - 2026.
 
Muscle Relaxant Drugs are a special class of drugs used in the treatment of several discomforts caused to the muscle like spasms, pain, and cramps due to dehydration or fatigue. These drugs do not act on the central nervous system but work on the neurons used for signal transmission between the brain and the spinal cord. They are used during surgical procedures as well to relax the muscles. Few of the muscle relaxant drugs currently in the market approved by the FDA are baclofen, metaxalone, and orphenadrine. Generally, muscle relaxants are very powerful drugs which are addictive and can have side effects. Drugs used for removing wrinkles on the face like Botox can also be fit under this class of drugs since their use is like that of a relaxant.
 
Market Dynamics
 
The growing geriatric population and changing lifestyles are the main drivers of the muscle relaxant drugs market. The rise in the number of surgical procedures carried out globally and the use of these drugs along with anaesthetic to relax a patient's muscle can further propel the growth of this market. Increased rate of pollution and exposure to UV rays can cause certain skin conditions which can be treated using these drugs. The market for muscle relaxant drugs will show a great deal of growth during COVID-19 lockdown since many people can suffer from muscular discomforts due to lack of physical activity. Stringent rules imposed by governments, risks involved, and high costs associated with the drugs can obscure the growth of the muscle relaxant drugs market.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of muscle relaxant drugs.
 
Market Segmentation
 
The entire muscle relaxant drugs market has been sub-categorized into drug type and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Drug Type

  • Facial Muscle Relaxant Drugs
  • Skeletal Muscle Relaxant Drugs
  • Neuromuscular Blocking Agents
 
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for muscle relaxant drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Muscle Relaxant Drugs Market By Revenue (USD MN)
 

 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the muscle relaxant drugs market include Abbott Laboratories, Medtronic, Mallinckrodt, Vertical Pharmaceuticals, Par Sterile Products, Johnson & Johnson, SteriMax, Endo Pharmaceuticals. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                            
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Muscle Relaxant Drugs Market
       2.2. Global Muscle Relaxant Drugs Market Snapshot
 
3 . MUSCLE RELAXANT DRUGS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Muscle Relaxant Drugs Market
       3.3. Market Restraints of Muscle Relaxant Drugs Market
       3.4. Opportunities of Muscle Relaxant Drugs Market
       3.5. Trends of Muscle Relaxant Drugs Market
       3.6. Porter’s Five Force Analysis of Muscle Relaxant Drugs Market
       3.7. Muscle Relaxant Drugs Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Drug Type
           3.7.2 Market Attractive Analysis by Distribution Channel
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Muscle Relaxant Drugs Value Chain Analysis
       4.2. Muscle Relaxant Drugs Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Muscle Relaxant Drugs Raw Material Manufactures List
           4.2.3. Price Trend of Muscle Relaxant Drugs Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Muscle Relaxant Drugs Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Muscle Relaxant Drugs Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Muscle Relaxant Drugs Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Muscle Relaxant Drugs Market
 
6 . GLOBAL MUSCLE RELAXANT DRUGS MARKET ANALYSIS BY DRUG TYPE
       6.1 Overview by Drug Type
       6.2 Global Muscle Relaxant Drugs Market Analysis by Drug Type
       6.3 Market Analysis of Facial Muscle Relaxant Drugs by Regions
       6.4 Market Analysis of Skeletal Muscle Relaxant Drugs by Regions
       6.6 Market Analysis of Neuromuscular Blocking Agents by Regions
 
7 . GLOBAL MUSCLE RELAXANT DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       7.1 Overview by Distribution Channel
       7.2 Global Muscle Relaxant Drugs Market Analysis by Distribution Channel
       7.3 Market Analysis of Hospital Pharmacy by Regions
       7.4 Market Analysis of Retail Pharmacy by Regions
       7.5 Market Analysis of Online Pharmacy by Regions
 
8 . GLOBAL MUSCLE RELAXANT DRUGS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Muscle Relaxant Drugs Market Estimate by Market Segment
           8.3.3. North America Muscle Relaxant Drugs Market Estimate by Country
           8.3.4. United State
           8.3.5. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Muscle Relaxant Drugs Market Estimate by Market Segment
           8.4.3. Europe Muscle Relaxant Drugs Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.8 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Muscle Relaxant Drugs Market Estimate by Market Segment
           8.5.3. Asia Pacific Muscle Relaxant Drugs Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.8. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Muscle Relaxant Drugs Market Estimate by Market Segment
           8.6.3. Latin America Muscle Relaxant Drugs Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.8. Middle East & Africa
           8.8.1. Overview
           8.8.2. Middle East & Africa Muscle Relaxant Drugs Market Estimate by Market Segment
           8.8.3. Middle East & Africa Muscle Relaxant Drugs Market Estimate by Country
           8.8.4. Middle East
           8.8.5. Africa
 
9 . COMPETITIVE LANDSCAPE OF THE MUSCLE RELAXANT DRUGS COMPANIES
       9.1. Muscle Relaxant Drugs Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF MUSCLE RELAXANT DRUGS INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Abbott Laboratories
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Medtronic
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Mallinckrodt
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Vertical Pharmaceuticals
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Par Sterile Products
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Johnson & Johnson
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. SteriMax
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Endo Pharmaceuticals
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Muscle Relaxant Drugs Market Snapshot
  • Drivers of The Global Muscle Relaxant Drugs Market Impact Analysis
  • Restraints of The Global Muscle Relaxant Drugs Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Muscle Relaxant Drugs Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Muscle Relaxant Drugs Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Muscle Relaxant Drugs Market
  • Global Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • Global Muscle Relaxant Drugs Market Analysis in Facial Muscle Relaxant Drugs by Geography (USD MN)
  • Global Muscle Relaxant Drugs Market Analysis in Skeletal Muscle Relaxant Drugs by Geography (USD MN)
  • Global Muscle Relaxant Drugs Market Analysis in Neuromuscular Blocking Agents by Geography (USD MN)
  • Global Muscle Relaxant Drugs Market Analysis by Distribution Channel (USD MN)
  • Global Muscle Relaxant Drugs Market Analysis in Hospital Pharmacy by Geography (USD MN)
  • Global Muscle Relaxant Drugs Market Analysis in Retail Pharmacy by Geography (USD MN)
  • Global Muscle Relaxant Drugs Market Analysis in Online Pharmacy by Geography (USD MN)
  • Global Muscle Relaxant Drugs Market by Geography (USD MN)
  • North America Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • North America Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • North America Muscle Relaxant Drugs Market Estimate by Country (USD MN)
  • United State Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • United State Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • Rest of North America Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • Rest of North America Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • Europe Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • Europe Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • United Kingdom Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • United Kingdom Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • France Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • France Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • Germany Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • Germany Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • Rest of Europe Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • Rest of Europe Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • Asia Pacific Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Muscle Relaxant Drugs Market Estimate by Country (USD MN)
  • China Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • China Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • Japan Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • Japan Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • India Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • India Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • Rest of Asia Pacific Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • Rest of Asia Pacific Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • Latin America Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • Latin America Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • Latin America Muscle Relaxant Drugs Market Estimate by Country (USD MN)
  • Brazil Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • Brazil Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • Rest of Latin America Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • Rest of Latin America Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • Middle East & Africa Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Muscle Relaxant Drugs Market Estimate by Country (USD MN)
  • Middle East Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • Middle East Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • Africa Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • Africa Muscle Relaxant Drugs Market Estimate by Distribution Channel (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Muscle Relaxant Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Muscle Relaxant Drugs Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Drug Type
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Muscle Relaxant Drugs Market Analysis by Drug Type (USD MN)
  • Global Muscle Relaxant Drugs Market Analysis in Facial Muscle Relaxant Drugs by Geography (USD MN)
  • Global Muscle Relaxant Drugs Market Analysis in Skeletal Muscle Relaxant Drugs by Geography (USD MN)
  • Global Muscle Relaxant Drugs Market Analysis in Neuromuscular Blocking Agents by Geography (USD MN)
  • Global Muscle Relaxant Drugs Market Analysis by Distribution Channel (USD MN)
  • Global Muscle Relaxant Drugs Market Analysis in Hospital Pharmacy by Geography (USD MN)
  • Global Muscle Relaxant Drugs Market Analysis in Retail Pharmacy by Geography (USD MN)
  • Global Muscle Relaxant Drugs Market Analysis in Online Pharmacy by Geography (USD MN)
  • Latin America Muscle Relaxant Drugs Market by Revenue
  • Middle East & Africa Muscle Relaxant Drugs Market by Revenue
  • Recent Development in Muscle Relaxant Drugs Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials